Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryLI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology portfolio
Salary Range:CHF142,100.00 - CHF263,900.00 BandLevel 6 Job Description SummaryOffice Location: Basel, Switzerland #LI-Hybrid Hybrid (12 days per month on-site) Relocation Support: Novartis is unable to offer relocation support - please only apply if this location is
Therapeutic Area Biomarker Lead (TABL) Salary Range: CHF142,100.00 - CHF263,900.00 Location: Basel, Switzerland Job Description Summary As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development group, you are accountable for defining and delivering biomarker
Summary LI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology portfolio across multiple drug development programs
Ihr Profil: erste Berufserfahrung aus dem Lagerbereich bzw. aus genanntem Aufgabengebiet können Sie vorweisen Staplerschein mit guter Fahrpraxis sowie gute MS-Office Kenntnisse bringen Sie mit der Umgang mit diversen Warenwirtschaftsprogrammen, insbesondere mit BMD, ist Ihnen bekannt die
Office LocationBasel, Switzerland (Hybrid – 12 days per month on-site). Relocation support not provided; please only apply if you can access this location.About this roleMake a meaningful impact where science meets patient care—join us in shaping
Summary Office Location: Basel, Switzerland Hybrid (12 days per month on-site) Relocation Support: Novartis is unable to offer relocation support - please only apply if this location is accessible to you About This Role Make a
Summary LI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology portfolio across multiple drug development programs